フルテキストファイル | |
著者 |
Shinbori Chiko
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
Saito Motoaki
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
KAKEN
Kinoshita Yukako
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
KAKEN
Satoh Itaru
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
Kono Tomoharu
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
Hanada Takuya
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
Nanba Eiji
Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University
研究者総覧
KAKEN
Adachi Kaori
Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University
研究者総覧
KAKEN
Suzuki Hiroto
Meiji Dairies Corporation Pharmaceuticals Department
Yamada Masashi
Meiji Dairies Corporation Pharmaceuticals Department
Satoh Keisuke
Department of Pathophysiological and Therapeutic Science, Division of Molecular Pharmacology, Tottori University Faculty of Medicine
KAKEN
|
キーワード | N-hexacosanol
NOS
muscarinic M3 receptor
aorta
endothelium
diabetes
|
出版者 | Elsevier
|
資料タイプ |
学術雑誌論文
|
外部リンク | |
ISSN | 0014-2999
|
書誌ID | AA00639687
|
掲載誌名 | European Journal of Pharmacology
|
最新掲載誌名 |
European Journal of Pharmacology
|
巻 | 567
|
号 | 1-2
|
開始ページ | 139
|
終了ページ | 144
|
発行日 | 2007-07
|
出版者DOI | |
著者版フラグ |
著者版
|
掲載情報 | European journal of pharmacology. 2007, 567(1-2), 139–144
|
部局名 |
医学部・医学系研究科・医学部附属病院
|
言語 |
英語
|